Analyst Ratings for CME Group (CME)
CME Rating Summary
CME Price Target Summary
- Highest: $235.00 (Citi)
- Lowest: $140.00 (Rosenblatt)
- Average: $197.88
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$197.88 (-4.9%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 39%
Avg. $ Target:
$197.88 (-4.9%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 39%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2021 | Argus | Stephen Biggar | Downgrade | Hold (Buy) |
N/A (N/A) |
203.73 (208.05) |
2.12% | Details |
| 3/24/2021 | BofA Securities | Michael Carrier | Upgrade | Buy (Neutral) |
220.00 (200.00) |
199.93 (208.05) |
4.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
